Evidence map›Paper›PMID 34272695›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Crystal Structures of Drug-Metabolizing CYPs.

D Fernando Estrada, Amit Kumar, Christopher S Campomizzi, Natalie Jay

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D Fernando EstradaDepartment of Biochemistry, University at Buffalo, Buffalo, NY, USA. dfestrad@buffalo.edu.
Amit KumarDepartment of Biochemistry, University at Buffalo, Buffalo, NY, USA.
Christopher S CampomizziDepartment of Biochemistry, University at Buffalo, Buffalo, NY, USA.
Natalie JayDepartment of Biochemistry, University at Buffalo, Buffalo, NY, USA.
University at Buffalo, State University of New York · US

Funding

Structural regulation of Class-I and Class-II cytochrome P450 enzymesR35GM133375 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI David Fernando Estrada · 2019 to 2026
$3.0M
NIGMS NIH HHS R35 GM133375
6 · The paper itself

Abstract

The complex enzyme kinetics displayed by drug-metabolizing cytochrome P450 enzymes (CYPs) (see Chapter 9 ) can, in part, be explained by an examination of their crystallographic protein structures. Fortunately, despite low sequence similarity between different families of drug-metabolizing CYPs, there exists a high degree of structural homology within the superfamily. This similarity in the protein fold allows for a direct comparison of the structural features of CYPs that contribute toward differences in substrate binding, heterotropic and homotropic cooperativity, and genetic variability in drug metabolism. In this chapter, we first provide an overview of the nomenclature and the role of structural features that are common in all CYPs. We then apply these definitions to understand the different substrate specificities and functions in the CYP3A, CYP2C, and CYP2D families of enzymes.

Indexed as

Genetic VariationCrystallography, X-RayCytochrome P-450 Enzyme SystemHumansInactivation, MetabolicKineticsModels, MolecularProtein FoldingProtein Structure, SecondarySubstrate SpecificityCytochrome P-450 Enzyme SystemCrystal structureCytochrome P450Ligand bindingSNPSubstrate selectivity

Identifiers

PMID34272695
PMCPMC10813703
OpenAlexW3178345271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.